Advanced
search

Search results

1 – 1 of 1
View access options
Expert briefing
Publication date: 21 February 2024
Expert Briefings Powered by Oxford Analytica

Demand for the company's type 2 diabetes treatment, Ozempic, and its higher-dose version, Wegovy, has surged since November when the US Food and Drug Administration (FDA) approved…

Details

DOI: 10.1108/OXAN-DB285358

ISSN: 2633-304X

Keywords

Geographic
International
NA
United States
Topical
economy
capital flows
finance
health
investment
pharmaceutical
welfare

Access

Year

Last 6 months (1)

Content type

Refine By Country
{"U":[{"count":"1","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-geographic%3A%22INTERNATIONAL%22+AND+keyword-topical%3A%22investment%22+AND+keyword-topical%3A%22health%22&facet-sort-date=last-6-months&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-geographic%3A%22INTERNATIONAL%22+AND+keyword-topical%3A%22investment%22+AND+keyword-topical%3A%22health%22+AND+keyword-country%3A%22United+States%22&facet-sort-date=last-6-months&p=1"}]}
1 – 1 of 1
Manage cookies

We’re listening — tell us what you think

Join us on our journey